Evolent Health (EVH) Revenue (2015 - 2026)

Evolent Health's Revenue history runs 12 years deep, the most recent figure standing at $496.2 million for Q1 2026.

• On a quarterly basis, Revenue rose 2.6% year-over-year to $496.2 million in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 21.26% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 26.56% from the prior year.
• Revenue advanced to $496.2 million in Q1 2026 per EVH's latest filing, from $468.7 million in the prior quarter.
• Across five years, Revenue topped out at $647.1 million in Q2 2024 and bottomed at $297.1 million in Q1 2022.
• The 5-year median for Revenue is $479.5 million (2025), against an average of $484.9 million.
• Across the five-year window, Revenue jumped 58.49% in 2022 and plunged 31.34% in 2025, its largest moves.
• Year by year, Revenue stood at $382.4 million in 2022, then jumped by 45.4% to $556.1 million in 2023, then climbed by 16.27% to $646.5 million in 2024, then slipped by 27.5% to $468.7 million in 2025, then increased by 5.87% to $496.2 million in 2026.
• Per Business Quant, the three latest EVH Revenue figures stand at $496.2 million (Q1 2026), $468.7 million (Q4 2025), and $479.5 million (Q3 2025).